Juvenescence enhances AI drug discovery with Ro5 acquisition

Juvenescence has acquired Ro5 to enhance its AI/machine learning capabilities and improve research and development.

Jun 7, 2025 - 06:00

Juvenescence enhances AI drug discovery with Ro5 acquisition

Juvenescence has acquired Ro5 to enhance its AI/machine learning capabilities and improve research and development.

Read the original article

Tags:

Previous Article

ADHD drugs back in the spotlight after study debunks rising prevalence

EC authorises Sydnexis’ paediatric myopia treatment

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

NPX-267 by NextPoint Therapeutics for Cervical Cancer: Likelihood of Approval

NPX-267 by NextPoint Therapeutics for Cervical Cancer: ...

Jun 14, 2024

STAT+: AstraZeneca sues to stop Medicare drug price negotiation program

STAT+: AstraZeneca sues to stop Medicare drug price neg...

Aug 25, 2023

Opinion: After 20 years in rehabilitation research, my young daughter’s traumatic brain injury transformed my mind and my career

Opinion: After 20 years in rehabilitation research, my ...

Jan 24, 2024